Published in PLoS One on July 06, 2012
3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells. Stem Cell Reports (2014) 2.42
Tissue-engineered models of human tumors for cancer research. Expert Opin Drug Discov (2015) 0.95
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activation. Mol Endocrinol (2014) 0.89
Engineering cancer microenvironments for in vitro 3-D tumor models. Mater Today (Kidlington) (2015) 0.81
Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation. World J Gastroenterol (2014) 0.80
Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater (2015) 0.78
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures. J Biomol Screen (2016) 0.77
Human tissue models in cancer research: looking beyond the mouse. Dis Model Mech (2017) 0.75
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep (2016) 0.75
Three-dimensional model of mouse epidermis for experimental studies of psoriasis. Acta Naturae (2013) 0.75
Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model. PLoS One (2017) 0.75
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 14.40
Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol (2009) 9.87
Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer (2004) 9.68
A tense situation: forcing tumour progression. Nat Rev Cancer (2009) 7.80
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60
Trophic macrophages in development and disease. Nat Rev Immunol (2009) 5.37
The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12
Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol (2010) 4.33
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev (2008) 3.33
The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 3.33
Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol (2008) 3.02
CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem (2009) 2.81
Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol (2010) 2.79
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell (2000) 2.35
Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol (2010) 2.07
Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol (2007) 1.88
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci U S A (2010) 1.55
Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol (1999) 1.51
Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol (2011) 1.44
Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog (1998) 1.42
Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol (1983) 1.36
Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res (1998) 1.33
Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol (2011) 1.24
Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res (2004) 1.21
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res (2006) 1.13
Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol (2006) 1.09
IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int J Cancer (2010) 1.09
Organotypic culture, a powerful model for studying rat and mouse fetal testis development. Cell Tissue Res (2006) 1.06
Müller and macrophage-like cell interactions in an organotypic culture of porcine neuroretina. Mol Vis (2008) 0.98
Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J Investig Dermatol Symp Proc (2006) 0.98
Organotypic cocultures as skin equivalents: A complex and sophisticated in vitro system. Biol Proced Online (2004) 0.97
Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer (1999) 0.91
Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am J Pathol (2009) 0.87
A new organotypic model containing dermal-type macrophages. Exp Dermatol (2011) 0.87
Routine testing of cell cultures and their products for mycoplasma contamination. Methods Mol Biol (1997) 0.84
Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation. J Cancer Res Clin Oncol (1987) 0.83
Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab (1995) 0.82
A macrophage hippocampal slice co-culture system: application to the study of HIV-induced brain damage. J Neurosci Methods (1999) 0.80
Effect of interferon alpha, interferon beta, and interferon gamma on the in vitro growth of human renal adenocarcinoma cells. Invest New Drugs (1987) 0.77
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res (2007) 2.01
Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. J Pathol (2012) 1.87
The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe (2009) 1.74
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther (2008) 1.58
Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med (2004) 1.36
Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics (2002) 1.23
Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res (2004) 1.21
Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol (2005) 1.20
MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis (2009) 1.20
Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol (2004) 1.17
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia (2004) 1.13
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res (2006) 1.13
Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer (2002) 1.12
IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int J Cancer (2010) 1.09
Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia (2005) 1.06
The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol. Infect Immun (2007) 1.03
RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Radiology (2009) 1.01
Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res (2003) 0.97
Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol (2007) 0.93
Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol (2006) 0.93
Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett (2009) 0.91
GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med (2012) 0.91
The C terminus of YopT is crucial for activity and the N terminus is crucial for substrate binding. Infect Immun (2003) 0.90
Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Int J Cancer (2009) 0.90
MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression. Anticancer Res (2010) 0.88
Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am J Pathol (2009) 0.87
Caspase-1 activation via Rho GTPases: a common theme in mucosal infections? PLoS Pathog (2010) 0.85
Inflammation and skin cancer: old pals telling new stories. Cancer J (2013) 0.81
Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis (2006) 0.81
Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization. J Neurooncol (2004) 0.80
Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth. Int J Cancer (2014) 0.80
A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: a contribution to understand colloidal protein stabilisation. Biophys Chem (2009) 0.80
Testosterone supplementation for hypogonadal men by the nasal route. Aging Male (2008) 0.80
Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen. Int J Cancer (2014) 0.75
Preparation and application of cellular and nanoporous carbides. Chem Soc Rev (2012) 0.75